| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/24/2006 | US20060188462 Skin care compositions containing a sugar amine |
| 08/24/2006 | US20060188453 N,N'-bis(2.4-dibenzylamino)-6-methylpyrimidine, N,N'-bis(2.4-diphenylethylamino)-6-methylpyrimidine, for example; antiseptics, deodorants |
| 08/24/2006 | US20060188450 System and method for suppressing a cough |
| 08/24/2006 | US20060188449 Topical aerosol foams |
| 08/24/2006 | US20060188443 Diagnostic composition for diabetes type-2 and impaired glucose tolerance, and methods of use |
| 08/24/2006 | US20060188442 X-ray guided drug delivery |
| 08/24/2006 | US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 08/24/2006 | DE102005008312A1 Verwendung deuterierter N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]acatamide und deren pharmazeutisch verträglicher Salze sowie diese Verbindungen enthaltende Arzneimittel Using deuterated N- [2- (5-methoxy-1H-indol-3-yl) -ethyl] acatamide and their pharmaceutically acceptable salts as well as medicaments containing these compounds |
| 08/24/2006 | DE102005008310A1 Verwendung von CDKII Inhibitoren zur Fertilitätskontrolle Use of CDKII inhibitors for birth control |
| 08/24/2006 | DE102005008309A1 Pharmazeutische Mittel enthaltend fluoralkylhaltige Metallkomplexe und Epothilone Pharmaceutical preparations containing fluoroalkyl-containing metal complexes and epothilones |
| 08/24/2006 | DE102005007739A1 Tetrazinderivate mit antimykotischer Wirkung und ihre Verwendung Tetrazine derivatives with antifungal activity and their use |
| 08/24/2006 | DE102005007654A1 Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen New long-acting beta-mimetics for the treatment of respiratory disorders |
| 08/24/2006 | DE102005007304A1 Triazolderivate Triazole derivatives |
| 08/24/2006 | DE102005006539A1 Biguanid enthaltende Zusammensetzungen Biguanide-containing compositions |
| 08/24/2006 | DE102005006104A1 Aqueous based agents, useful as e.g. cosmetic disinfectant and cleaner, comprises inorganic alkali- and/or alkaline- earth salts, monovalent alcohols, cationic surfactants and optionally additives and/or auxiliary materials |
| 08/24/2006 | DE102004046142B4 Neue selektiv wirksame Substanzen zur Behandlung von Krankheiten, die durch Mykobakterien hervorgerufen werden, Verfahren zu ihrer Herstellung und ihre Verwendung Selectively new active substances for the treatment of diseases which are caused by mycobacteria, processes for their preparation and their use |
| 08/24/2006 | DE10150824B4 Konzentrat, seine Herstellung und Verwendung Concentrate, its preparation and use |
| 08/24/2006 | DE10040742B4 Mittel zur Herz-Kreislauf-Protektion Means for cardiovascular-protection |
| 08/24/2006 | CA2836652A1 Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition |
| 08/24/2006 | CA2770430A1 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases |
| 08/24/2006 | CA2642734A1 Immunostimulating polyphosphazene compounds |
| 08/24/2006 | CA2642429A1 L-aspartic acid for the treatment of problems in connection with the fat or glucose metabolism |
| 08/24/2006 | CA2621047A1 Method of treating eye injury with local administration of a vegf inhibitor |
| 08/24/2006 | CA2614068A1 Methods and compositions related to the modulation of intercellular junctions |
| 08/24/2006 | CA2599046A1 Antitumor agent |
| 08/24/2006 | CA2598988A1 Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing the same as nhe inhibitors |
| 08/24/2006 | CA2598489A1 Piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598484A1 Inhibition or treatment of dyskinesia |
| 08/24/2006 | CA2598465A1 Substituted pyrido (2 , 3-d) pyrimidine derivatives useful as medicines for the treatment of autoimmune disorders |
| 08/24/2006 | CA2598460A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598459A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/24/2006 | CA2598458A1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598457A1 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598456A1 Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 08/24/2006 | CA2598451A1 Compounds inhibiting the aggregation of superoxide dismutase-1 |
| 08/24/2006 | CA2598448A1 Antiangiogenic agents with aldesleukin |
| 08/24/2006 | CA2598423A1 Antibacterial piperidine derivatives |
| 08/24/2006 | CA2598416A1 Kappa opioid receptor ligands |
| 08/24/2006 | CA2598410A1 Oral pharmaceutical for of losartan |
| 08/24/2006 | CA2598409A1 Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation |
| 08/24/2006 | CA2598407A1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using them |
| 08/24/2006 | CA2598355A1 Novel, long-acting betamimetics for treating respiratory diseases |
| 08/24/2006 | CA2598301A1 Salt of proline derivative, solvate thereof, and production method thereof |
| 08/24/2006 | CA2598273A1 Method of treating atherosclerosis, dyslipidemias and related conditions |
| 08/24/2006 | CA2598271A1 Pharmacokinetically improved compounds |
| 08/24/2006 | CA2598270A1 Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds |
| 08/24/2006 | CA2598239A1 Nanoparticulate formulations of taxanes and carrier proteins for use in combination chemotherapy |
| 08/24/2006 | CA2598218A1 Substances, compositions and methods for treating alopecia |
| 08/24/2006 | CA2598159A1 Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury |
| 08/24/2006 | CA2598087A1 5-[4-(4-(2-amino-2 methoxycarbonylethyl)phenoxy)benzilidene]thiazolidin-2,4-dione derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma |
| 08/24/2006 | CA2598076A1 Chemical compounds |
| 08/24/2006 | CA2598017A1 Triazole derivatives |
| 08/24/2006 | CA2597982A1 Boron-containing small molecules |
| 08/24/2006 | CA2597962A1 Benzoxazole carboxamides for treating cinv and ibs-d |
| 08/24/2006 | CA2597942A1 Pharmaceutical compositions comprising anticholinergics and etiprednol |
| 08/24/2006 | CA2597935A1 Compounds useful for treating hiv |
| 08/24/2006 | CA2597933A1 Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody |
| 08/24/2006 | CA2597930A1 New isothiazoloquinolones and related compounds as anti-infective agents |
| 08/24/2006 | CA2597910A1 Dosage form and method for sustained release of a substituted pyrazine compound |
| 08/24/2006 | CA2597903A1 Cationic lipids for the transfection of nucleic acids |
| 08/24/2006 | CA2597896A1 1h-imidazole derivatives as cannabinoid cb2 receptor modulators |
| 08/24/2006 | CA2597870A1 9-substituted tetracyclines |
| 08/24/2006 | CA2597816A1 Compounds |
| 08/24/2006 | CA2597813A1 Chemical compounds |
| 08/24/2006 | CA2597717A1 Antibodies against cxcr4 and methods of use thereof |
| 08/24/2006 | CA2597682A1 C10 cyclopropyl ester substituted taxane compositions |
| 08/24/2006 | CA2597655A1 Flavivirus replicon constructs for tumour therapy |
| 08/24/2006 | CA2597651A1 Device for delivery of trpv1 agonists |
| 08/24/2006 | CA2597622A1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | CA2597620A1 Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | CA2597616A1 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 08/24/2006 | CA2597609A1 Use of eicosapentaenoic acid for decreasing cartilage damage in dogs |
| 08/24/2006 | CA2597498A1 Therapeutic combinations of manidi pine and a statin |
| 08/24/2006 | CA2597359A1 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |
| 08/24/2006 | CA2597269A1 1-substituted-7-(beta-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 08/24/2006 | CA2597245A1 Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
| 08/24/2006 | CA2596990A1 Sphingosine 1-phosphate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups |
| 08/24/2006 | CA2596984A1 Use of estrogen receptor-beta selective agonists for radiation-or chemotherapy-induced mucositis and radiation cystitis |
| 08/24/2006 | CA2596960A1 Method of modulating drug release from a coated substrate |
| 08/24/2006 | CA2596922A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 08/24/2006 | CA2596873A1 Methods and compositions for the treatment of lipid-associated disorders |
| 08/24/2006 | CA2596768A1 A method for treating heart failure |
| 08/24/2006 | CA2596664A1 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis |
| 08/24/2006 | CA2596522A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters |
| 08/24/2006 | CA2596392A1 Orally bioavailable cci-779 tablet formulations |
| 08/24/2006 | CA2596015A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
| 08/24/2006 | CA2595936A1 Substituted pyrazoles as modulators of chemokine receptors |
| 08/24/2006 | CA2595931A1 Methods of using death receptor agonists and egfr inhibitors |
| 08/24/2006 | CA2595926A1 Soap scent patch and treatment for muscle spasm and pain |
| 08/24/2006 | CA2595620A1 Compositions for treatment of diseases of the nail unit |
| 08/24/2006 | CA2595564A1 Use of .beta.-lapachone and related naphthoquinones in the treatment of amp-activated protein kinase (ampk) mediated disorders |
| 08/24/2006 | CA2595411A1 Oral dosage form comprising rosiglitazone |
| 08/24/2006 | CA2595368A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
| 08/24/2006 | CA2595269A1 Composition comprising ocaperidone |
| 08/24/2006 | CA2594939A1 Solid peroral contraceptive drug |
| 08/24/2006 | CA2594820A1 Macrolides with anti-inflammatory activity |
| 08/24/2006 | CA2590004A1 Contraceptive pharmaceutical preparation |
| 08/24/2006 | CA2584614A1 Antisense modulation of integrin .alpha.4 expression |
| 08/24/2006 | CA2582262A1 Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 08/24/2006 | CA2572151A1 Oligonucleotides comprising a non-phosphate backbone linkage |